Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis
Jincheng Xu, Xiaoyue Xu, Lina Jiang, et al.
Respiratory Research (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
Stephany Beyerstedt, Expedito Barbosa Casaro, Érika Bevilaqua Rangel
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 5, pp. 905-919
Open Access | Times Cited: 728
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Toni Delorey, Carly G.K. Ziegler, Graham Heimberg, et al.
Nature (2021) Vol. 595, Iss. 7865, pp. 107-113
Open Access | Times Cited: 715
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Vrishali S. Salian, Jessica Wright, Peter T. Vedell, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 3, pp. 754-771
Closed Access | Times Cited: 300
Transcriptional and proteomic insights into the host response in fatal COVID-19 cases
Meng–Huang Wu, Yaobing Chen, Han Xia, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 45, pp. 28336-28343
Open Access | Times Cited: 186
Animal and translational models of SARS-CoV-2 infection and COVID-19
Matt D. Johansen, Aaron T. Irving, Xavier Montagutelli, et al.
Mucosal Immunology (2020) Vol. 13, Iss. 6, pp. 877-891
Open Access | Times Cited: 176
Therapeutic targets in lung tissue remodelling and fibrosis
Gang Liu, Ashleigh M. Philp, Tamera J. Corte, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107839-107839
Open Access | Times Cited: 175
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
I Bernard, Daniel Limonta, Lara K. Mahal, et al.
Viruses (2020) Vol. 13, Iss. 1, pp. 29-29
Open Access | Times Cited: 160
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review
Eleni Korompoki, Maria Gavriatopoulou, Rachel Hicklen, et al.
Journal of Infection (2021) Vol. 83, Iss. 1, pp. 1-16
Open Access | Times Cited: 158
CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge
Bavithra Vijayakumar, James Tonkin, Anand Devaraj, et al.
Radiology (2021) Vol. 303, Iss. 2, pp. 444-454
Open Access | Times Cited: 136
Pulmonary fibrosis secondary to COVID-19: a narrative review
Suzana Érico Tanni, Alexandre Todorovic Fabro, André Luís Pereira de Albuquerque, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 6, pp. 791-803
Closed Access | Times Cited: 133
Nutrition in the Actual COVID-19 Pandemic. A Narrative Review
Vicente Javier Clemente‐Suárez, Domingo Jesús Ramos‐Campo, Juan Mielgo‐Ayuso, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1924-1924
Open Access | Times Cited: 109
Virus infection induced pulmonary fibrosis
Wei Huang, Xiao Xiao Tang
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 108
Comparative analysis of cell–cell communication at single-cell resolution
Aaron J. Wilk, Alex K. Shalek, Susan Holmes, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 3, pp. 470-483
Open Access | Times Cited: 59
Long COVID and rehabilitation
Hung‐Jui Chuang, Chia-Wei Lin, Ming‐Yen Hsiao, et al.
Journal of the Formosan Medical Association (2023) Vol. 123, pp. S61-S69
Open Access | Times Cited: 52
Long-term Radiological and Pulmonary Function Abnormalities at 3-year post COVID-19 Hospitalization: A Longitudinal Cohort Study
Xiaoyu Han, Lu Chen, Li-Yan Guo, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 1, pp. 2301612-2301612
Open Access | Times Cited: 15
Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery
Zihao Chen, Ning Zhang, Hang Yin Chu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 113
Post-COVID lung fibrosis
ZarirF Udwadia, Parvaiz A Koul, Luca Richeldi
Lung India (2020) Vol. 38, Iss. Suppl 1, pp. S41-S47
Open Access | Times Cited: 92
MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
Christine Hum, Julia Loiselle, Nadine Ahmed, et al.
Drugs (2021) Vol. 81, Iss. 5, pp. 517-531
Open Access | Times Cited: 76
Rationale for azithromycin in COVID-19: an overview of existing evidence
Iwein Gyselinck, Wim Janssens, Peter Verhamme, et al.
BMJ Open Respiratory Research (2021) Vol. 8, Iss. 1, pp. e000806-e000806
Open Access | Times Cited: 72
Immunopathology of galectin-3: an increasingly promising target in COVID-19
John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, et al.
F1000Research (2020) Vol. 9, pp. 1078-1078
Open Access | Times Cited: 70
Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-Chip
Amir Bein, Seong‐Min Kim, Girija Goyal, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 67
Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114812-114812
Open Access | Times Cited: 62
Mesenchymal stem cell treatment for COVID-19
Ruonan Xu, Zhiqian Feng, Fu‐Sheng Wang
EBioMedicine (2022) Vol. 77, pp. 103920-103920
Open Access | Times Cited: 56
Coronavirus Infection and Cholesterol Metabolism
Jun Dai, Huan Wang, Ying Liao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
SARS-CoV-2 Infection and Lung Regeneration
Fuxiaonan Zhao, Qingwen Ma, Qing Yue, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 2
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top